Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2026-05-18 16:08:07 ET · period of report 2026-05-15 · accession 0001771498-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-18 16:08 | 2026-05-15 | INO | Shea Jacqueline Elizabeth | CEO, Dir | M - OptEx | — | +17.7K | 102.7K | +21% | — |
| D | 2026-05-18 16:08 | 2026-05-15 | INO | Shea Jacqueline Elizabeth | CEO, Dir | F - Tax | $1.30 | -7,717 | 95.0K | -8% | -$10.0K |
| D | 2026-05-18 16:08 | 2026-05-15 | INO | Shea Jacqueline Elizabeth | CEO, Dir | M - OptEx | $0.00 | -17.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-15 | M | A | 17,744 | — | 102,748 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both. |
| 2 | Common | Common Stock | 2026-05-15 | F | D | 7,717 | $1.30 | 95,031 | D | — | — | (F2) The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. |
| 3 | Derivative | Restricted Stock Unit | 2026-05-15 | M | D | 17,744 | $0.00 | 0 | D | — · — to — | 17,744 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both. (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both. (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both. |